IMGT Co.,Ltd. (XKON: 456570)
12,740
0.00 (0.00%)
At close: Sep 10, 2024
IMGT Co.,Ltd. Company Description
IMGT Co.,Ltd. engages in researching and developing of an ultrasound-guided therapy technology for genetic therapy and drug delivery systems.
It develops IMGT-LPS, a technology that injects ultrasound-sensitive nanoparticles in the form of liposome-wrapped pharmacological substances into the body and releases drugs by irradiating ultrasound to the target area(tumor); IMGT-EMB, a nanoparticle for chemoembolization of liver cancer; IMGT-TSD, a targeted sonodynamic therapy that induces immune boosting mechanism by applying ultrasonic stimulation to the cancerous area; and IMGT-FUS, a device for non-invasive treatment.
The company was founded in 2010 and is based in Seongnam-si, South Korea.
IMGT Co.,Ltd.
Country | South Korea |
Founded | 2010 |
Industry | Biological Products, Except Diagnostic Substances |
CEO | Hakjong Lee |
Contact Details
Address: 408, Healthcare Innovation Park Seongnam-si, 13605 South Korea | |
Phone | 82 3 1994 7077 |
Website | nanoimgt.com |
Stock Details
Ticker Symbol | 456570 |
Exchange | Korea New Exchange |
Reporting Currency | KRW |
SIC Code | 2836 |
Key Executives
Name | Position |
---|---|
Hakjong Lee | Chief Executive Officer |